Themed issue on drug pricing policy and the Inflation Reduction Act
This themed issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) features articles exploring drug pricing policy, with a special focus on implementation of the Inflation Reduction Act drug pricing provisions. The Inflation Reduction Act of 2022 authorizes the Centers for Medicare & Medicaid Services (CMS) to negotiate the prices of top-selling Medicare Part B and D drugs with pharmaceutical manufacturers. How CMS implements this program has important implications for managed care pharmacy.